Evidence map›Paper›PMID 30888967›Full record

ArticleAging2019

Trends in the incidence of recurrent stroke at 5 years after the first-ever stroke in rural China: a population-based stroke surveillance from 1992 to 2017.

Wenjuan Zhao, Jialing Wu, Jie Liu, Yanan Wu, Jingxian Ni, Hongfei Gu, Jun Tu, Jinghua Wang, Zhongping An, Xianjia Ning

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05907694 (Medical Treatment With or Without Transcatheter Patent Foramen Ovale CloSure for Older Patients With CrypTogenic StrOke and Patent Foramen Ovale. The STOP Trial), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05907694 narecruitingnot on this mapstarted 2024, after this paper: background citation

Medical Treatment With or Without Transcatheter Patent Foramen Ovale CloSure for Older Patients With CrypTogenic StrOke and Patent Foramen Ovale. The STOP Trial

TypeinterventionalSponsorJosep Rodes-CabauRan2024 to 2037Enrolled714ConditionsPatent Foramen Ovale, Cryptogenic Stroke, Older Patients, Medical TreatmentArmsTranscatheter PFO closure, Optimal medical treatment
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Wenjuan ZhaoDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China.
Jialing WuDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China.
Jie LiuDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Yanan WuDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jingxian NiDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Hongfei GuDepartment of Neurology, Tianjin Haibin People's Hospital, Tianjin 300280, China.
Jun TuDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jinghua WangDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Zhongping AnDepartment of Neurology, Tianjin Huanhu Hospital, Tianjin 300350, China.
Xianjia NingDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Tianjin Medical University General Hospital · CNTianjin Huanhu Hospital · CNTianjin People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent data on the incidence and trends for recurrent strokes in China are scarce. We assessed the temporal trends in recurrent stroke incidence using in rural China. The age-standardized incidences of recurrent stroke, within 5 years of the incident stroke event, were estimated for 3 time periods: 1992-1998, 1999-2005, and 2006-2012. Among the 768 documented incident stroke cases, 26.3% of the patients experienced recurrent stroke within 5 years. The overall age-adjusted recurrent stroke incidence was 43.93 per 100,000 person-years (1992-2012). During the 2006-2012 period, the recurrent stroke incidence per 100,000 person-years was 107.79 in men, and 557.76 in individuals ≥65 years old. There were significant upward tendencies observed in this population across sex, age, or type of stroke (except for among individuals ≥65 years old with incident intracerebral hemorrhages). Compared with the recurrent stroke incidence observed in the 1992-1998 period, that observed during the 2006-2012 period was more than 3-fold higher; the greatest increase (6.8-fold) was observed in women. These findings suggest an urgent need to improve risk factor management and implement appropriate medical resources to contain this upward trend in recurrent stroke incidence and reduce the overall stroke burden in China.

Indexed as

AdultAgedAge FactorsCase-Control StudiesChinaFemaleHumansIncidenceMaleMiddle AgedPopulation SurveillanceProspective StudiesRecurrenceRural PopulationStrokeepidemiologyrecurrencestroketrend

Identifiers

PMID30888967
PMCPMC6461163
OpenAlexW2924104027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.